Intratumoral Heterogeneity of the Epigenome

Tali Mazor, Aleksandr Pankov, Jun S. Song, Joseph F. Costello

Research output: Contribution to journalReview article

Abstract

Investigation into intratumoral heterogeneity (ITH) of the epigenome is in a formative stage. The patterns of tumor evolution inferred from epigenetic ITH and genetic ITH are remarkably similar, suggesting widespread co-dependency of these disparate mechanisms. The biological and clinical relevance of epigenetic ITH are becoming more apparent. Rare tumor cells with unique and reversible epigenetic states may drive drug resistance, and the degree of epigenetic ITH at diagnosis may predict patient outcome. This perspective presents these current concepts and clinical implications of epigenetic ITH, and the experimental and computational techniques at the forefront of ITH exploration.

Original languageEnglish (US)
Pages (from-to)440-451
Number of pages12
JournalCancer Cell
Volume29
Issue number4
DOIs
StatePublished - Apr 11 2016

Fingerprint

Epigenomics
Genetic Heterogeneity
Drug Resistance
Neoplasms

ASJC Scopus subject areas

  • Oncology
  • Cell Biology
  • Cancer Research

Cite this

Intratumoral Heterogeneity of the Epigenome. / Mazor, Tali; Pankov, Aleksandr; Song, Jun S.; Costello, Joseph F.

In: Cancer Cell, Vol. 29, No. 4, 11.04.2016, p. 440-451.

Research output: Contribution to journalReview article

Mazor, T, Pankov, A, Song, JS & Costello, JF 2016, 'Intratumoral Heterogeneity of the Epigenome', Cancer Cell, vol. 29, no. 4, pp. 440-451. https://doi.org/10.1016/j.ccell.2016.03.009
Mazor, Tali ; Pankov, Aleksandr ; Song, Jun S. ; Costello, Joseph F. / Intratumoral Heterogeneity of the Epigenome. In: Cancer Cell. 2016 ; Vol. 29, No. 4. pp. 440-451.
@article{8276fff5112c4ae1a9a0c0dcc935d75e,
title = "Intratumoral Heterogeneity of the Epigenome",
abstract = "Investigation into intratumoral heterogeneity (ITH) of the epigenome is in a formative stage. The patterns of tumor evolution inferred from epigenetic ITH and genetic ITH are remarkably similar, suggesting widespread co-dependency of these disparate mechanisms. The biological and clinical relevance of epigenetic ITH are becoming more apparent. Rare tumor cells with unique and reversible epigenetic states may drive drug resistance, and the degree of epigenetic ITH at diagnosis may predict patient outcome. This perspective presents these current concepts and clinical implications of epigenetic ITH, and the experimental and computational techniques at the forefront of ITH exploration.",
author = "Tali Mazor and Aleksandr Pankov and Song, {Jun S.} and Costello, {Joseph F.}",
year = "2016",
month = "4",
day = "11",
doi = "10.1016/j.ccell.2016.03.009",
language = "English (US)",
volume = "29",
pages = "440--451",
journal = "Cancer Cell",
issn = "1535-6108",
publisher = "Cell Press",
number = "4",

}

TY - JOUR

T1 - Intratumoral Heterogeneity of the Epigenome

AU - Mazor, Tali

AU - Pankov, Aleksandr

AU - Song, Jun S.

AU - Costello, Joseph F.

PY - 2016/4/11

Y1 - 2016/4/11

N2 - Investigation into intratumoral heterogeneity (ITH) of the epigenome is in a formative stage. The patterns of tumor evolution inferred from epigenetic ITH and genetic ITH are remarkably similar, suggesting widespread co-dependency of these disparate mechanisms. The biological and clinical relevance of epigenetic ITH are becoming more apparent. Rare tumor cells with unique and reversible epigenetic states may drive drug resistance, and the degree of epigenetic ITH at diagnosis may predict patient outcome. This perspective presents these current concepts and clinical implications of epigenetic ITH, and the experimental and computational techniques at the forefront of ITH exploration.

AB - Investigation into intratumoral heterogeneity (ITH) of the epigenome is in a formative stage. The patterns of tumor evolution inferred from epigenetic ITH and genetic ITH are remarkably similar, suggesting widespread co-dependency of these disparate mechanisms. The biological and clinical relevance of epigenetic ITH are becoming more apparent. Rare tumor cells with unique and reversible epigenetic states may drive drug resistance, and the degree of epigenetic ITH at diagnosis may predict patient outcome. This perspective presents these current concepts and clinical implications of epigenetic ITH, and the experimental and computational techniques at the forefront of ITH exploration.

UR - http://www.scopus.com/inward/record.url?scp=84962707515&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84962707515&partnerID=8YFLogxK

U2 - 10.1016/j.ccell.2016.03.009

DO - 10.1016/j.ccell.2016.03.009

M3 - Review article

C2 - 27070699

AN - SCOPUS:84962707515

VL - 29

SP - 440

EP - 451

JO - Cancer Cell

JF - Cancer Cell

SN - 1535-6108

IS - 4

ER -